Differential effects of resveratrol and its naturally occurring methylether analogs on cell cycle and apoptosis in human androgen-responsive LNCaP cancer cells

Molecular Nutrition and Food Research

Volumn 54, Issue 3, 2010, Pages 335-344

  Wang, Thomas T Y ^a   Schoene, Norberta W ^a   Kim, Young S ^b   Mizuno, Cassia S ^c   Rimando, Agnes M ^c  

^a BELTSVILLE HUMAN NUTRITION RESEARCH CENTER   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

^c NATURAL PRODUCTS UTILIZATION RESEARCH UNIT   (United States)

Author keywords

Androgen; Cancer prevention; Estrogen; Phytochemicals; Stilbenes

Indexed keywords

3,5 DIHYDROXY 4' METHOXYSTILBENE; 3,5-DIHYDROXY-4'-METHOXYSTILBENE; ANTIANDROGEN; ANTIESTROGEN; ANTINEOPLASTIC AGENT; CDKN1A PROTEIN, HUMAN; CDKN1B PROTEIN, HUMAN; CYCLIN DEPENDENT KINASE INHIBITOR 1A; MESSENGER RNA; PINOSTILBENE; PROSTATE SPECIFIC ANTIGEN; PTEROSTILBENE; RESVERATROL; SIGNAL PEPTIDE; STILBENE DERIVATIVE;

APOPTOSIS; ARTICLE; CELL CYCLE; CELL PROLIFERATION; CHEMISTRY; COMPARATIVE STUDY; DOSE RESPONSE; DRUG EFFECT; GENE EXPRESSION REGULATION; GENETICS; HUMAN; MALE; METABOLISM; PATHOLOGY; PROSTATE TUMOR; STRUCTURE ACTIVITY RELATION; SYNTHESIS; TUMOR CELL LINE;

ANDROGEN ANTAGONISTS; ANTICARCINOGENIC AGENTS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; APOPTOSIS; CELL CYCLE; CELL LINE, TUMOR; CELL PROLIFERATION; CYCLIN-DEPENDENT KINASE INHIBITOR P21; DOSE-RESPONSE RELATIONSHIP, DRUG; ESTRADIOL ANTAGONISTS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; RNA, MESSENGER; STILBENES; STRUCTURE-ACTIVITY RELATIONSHIP;

VITACEAE;

EID: 77649305163     PISSN: 16134125     EISSN: 16134133     Source Type: Journal    
DOI: 10.1002/mnfr.200900143     Document Type: Article

References (48)

1. Jemal, A., Siegel, R., Ward, E., Murray, T. et al., Cancer statistics 2007. CA Cancer J. Clin. 2007, 57, 43-66.
2. Taplin, M. E., Balk, S. P., Androgen receptor: a key molecule in the progression of prostate cancer to hormone independence. J. Cell Biochem. 2004, 91, 483-490.
3. Ho, S. M., Estrogens and anti-estrogens: key mediators of prostate carcinogenesis and new therapeutic candidates. J. Cell Biochem. 2004, 91, 491-503.
4. Renehan, A. G., Zwahlen, M., Minder, C., O'Dwyer, S. T. et al., Insulin-like growth factor (IGF)-I, IGF binding protein- 3, and cancer risk: systematic review and meta-regression analysis. Lancet 2004, 363, 1346-1353.
5. Lieberman, R., Chemoprevention of prostate cancer: current status and future directions. Cancer Metastasis Rev. 2002, 21,297-309.
6. Moschos, S. J., Mantzoros, C. S., The role of the IGF system in cancer: from basic to clinical studies and clinical applications. Oncology 2002, 63, 317-332.
7. So, A. I., Hurtado-Coll, A., Gleave, M. E., Androgens and prostate cancer. World J. Urol. 2003, 21, 325-337.
8. Kris-Etherton, P. M., Hecker, K. D., Bonanome, A., Coval, S. M. et al., Bioactive compounds in foods: their role in the prevention of cardiovascular disease and cancer. Am. J. Med. 2002, 113, 71S-88S
9. Stewart, J. R., Artime, M. C., O'Brian, C. A., Resveratrol: A candidate nutritional substance for prostate cancer prevention. J. Nutr. 2003, 133, 2440S-2443S
10. Hain, R., Bieseler, B., Kindl, H., Schroder, G., Stocker, R., Expression of a stilbene synthase gene in Nicotiana taba- cum results in synthesis of the phytoalexin resveratrol. Plant Mol. Biol. 1990, 15, 325-335.
11. Bhat, K. P. L., Kosmeder, J. W., II, Pezzuto, J. M., Biological effects of resveratrol. Antioxid. Redox Signal 2001, 3, 1041-1064.
12. Goldberg, D. M., Tsang, E., Karumanchiri, A., Diamandis, E. et al., Method to assay the concentrations of phenolic constituents of biological interest in wines. Anal. Chem. 1996,68,1688-1694.
13. Baur, J. A., Sinclair, D. A., Therapeutic potential of resveratrol: the in vivo evidence. Nat. Rev. Drug Discov. 2006, 5, 493-506.
14. Jang, M., Cai, L., Udeani, G. O., Slowing, K. V. et al., Cancer chemopreventive activity of resveratrol, a natural product derived from grapes. Science 1997, 275, 218-220.
15. Whitehead, T. P., Robinson, D., Allaway, S., Syms, J., Hale, A., Effect of red wine ingestion on the antioxidant capacity of serum. Clin. Chem. 1995, 41, 32-35.
16. Gehm, B. D., Levenson, A. S., Liu, H., Lee, E. J. et al., Estrogenic effects of resveratrol in breast cancer cells expressing mutant and wild-type estrogen receptors: role of AF-1 and AF-2. J. Steroid Biochem. Mol. Biol. 2004, 88, 223-234.
17. Hsieh, T. C., Wu, J. M., Differential effects on growth, cell cycle arrest, and induction of apoptosis by resveratrol in human prostate cancer cell lines. Exp. Cell Res. 1999, 249, 109-115.
18. Kim, Y. A., Rhee, S. H., Park, K. Y., Choi, Y. H., Anti-proliferative effect of resveratrol in human prostate carcinoma cells. J. Med. Food 2003, 6, 273-280.
19. Kuwajerwala, N., Cifuentes, E., Gautam, S., Menon, M. et al., Resveratrol induces prostate cancer cell entry into S phase and inhibits DNA synthesis. Cancer Res. 2002, 62, 2488-2492.
20. Lin, H. Y., Shih, A., Davis, F. B., Tang, H. Y. et al., Resveratrol induced serine phosphorylation of p53 causes apoptosis in a mutant p53 prostate cancer cell line. J. Urol. 2002, 168, 748-755.
21. Narayanan, B. A., Narayanan, N. K., Re, G. G., Nixon, D. W., Differential expression of genes induced by resveratrol in LNCaP cells: P53-mediated molecular targets. Int. J. Cancer 2003,104,204-212.
22. Jones, S. B., DePrimo, S. E., Whitfield, M. L., Brooks, J. D., Resveratrol-induced gene expression profiles in human prostate cancer cells. Cancer Epidemiol. Biomarkers Prev. 2005,14,596-604.
23. Nelson, P. S., Clegg, N., Arnold, H., Ferguson, C. et al., The program of androgen-responsive genes in neoplastic prostate epithelium. Proc. Natl. Acad. Sci. USA 2002, 99, 11890-11895
24. Huang, H., Tindall, D. J., The role of the androgen receptor in prostate cancer. Crit. Rev. Eukaryot. Gene Expr. 2002, 12, 193-207.
25. Takahashi, Y., Perkins, S. N., Hursting, S. D., Wang, T. T., 17beta-Estradiol differentially regulates androgen-responsive genes through estrogen receptor-beta- and extra-cellular-signal regulated kinase-dependent pathways in LNCaP human prostate cancer cells. Mol. Carcinog. 2007, 46,117-129.
26. Pozo-Guisado, E., Lorenzo-Benayas, M. J., Fernandez-Salguero, P. M., Resveratrol modulates the phosphoinosi-tide 3-kinase pathway through an estrogen receptor alpha-dependent mechanism: relevance in cell proliferation. Int. J. Cancer 2004, 109, 167-173.
27. 0-kinase/Akt pathway and Bcl-2 family proteins. Mol. Cancer Ther. 2006, 5, 1335-1341.
28. Harper, C. E., Patel, B. B., Wang, J., Arabshahi, A. et al., Resveratrol suppresses prostate cancer progression in transgenic mice. Carcinogenesis 2007, 28, 1946-1953
29. 0-trimethoxy-stilbene. Biofactors 2006, 27, 37-46.
30. Kerem, Z., Regev-Shoshani, G., Flaishman, M. A., Sivan, L., Resveratrol and two monomethylated stilbenes from Israeli Rumex bucephalophorus and their antioxidant potential. J. Nat. Prod. 2003, 66, 1270-1272.
31. Kumar, R. J., Jyostna, D., Krupadanam, G. L., Srimannar-ayana, G., Phenanthrene and stilbenes from Pterolobium hexapetallum. Phytochemistry 1988, 27, 3625-3626
32. Matsuda, H., Tewtrakul, S., Morikawa, T., Yoshikawa, M., Anti-allergic activity of stilbenes from Korean rhubarb (Rheum undulatum L.): structure requirements for inhibition of antigen-induced degranulation and their effects on the release of TNF-a and IL-4 in RBL-2H3 cells. Bioorg. Med. Chem. 2004, 12, 4871-4876.
33. Rimando, A. M., Kalt, W., Magee, J. B., Dewey, J., Balling-ton, J. R., Resveratrol, pterostilbene and piceatannol in Vaccinium berries. J. Agric. Food Chem. 2004, 52, 4713-4719.
34. Rimando, A. M., Barney, D. L., Resveratrol and naturally occurring analogues in Vaccinium species. Acta Hort. 2005, 680,137-143.
35. Wang, J., Matsuzaki, K., Kitanaka, S., Anti-allergic agents from natural sources. 19. Stilbene derivatives from Pholidota chinensis and their anti-inflammatory activity. Chem. Pharm. Bull. 2006, 54, 1216-1218.
36. Rimando, A. M., Cuendet, M., Desmarchelier, C., Mehta, R. G. et al., Cancer chemopreventive and antioxidant activities of pterostilbene, a naturally occurring analogue of resveratrol. J. Agric. Food Chem. 2002, 50, 3453-3457
37. Horvath, Z., Marihart-Fazekas, S., Saiko, P., Grusch, M. et al., Novel resveratrol derivatives induce apoptosis and cause cell cycle arrest in prostate cancer cell lines. Anti-cancer Res. 2007, 27, 3459-3464.
38. Cardile, V., Chillemi, R., Lombardo, L., Sciuto, S. et al., Antiproliferative activity of methylated analogues of E- and Z-resveratrol. J. Biosci. 2007, 62, 189-195.
39. 0-trimethoxy- stilbene. BioFactors 2006, 27, 37-46.
40. Pettit, G. R., Singh, S. B., Schmidt, J. M., Niven, M. L. et al., Isolation, structure, synthesis, and antimitotic properties of combretastatins B-3 and B-4 from Combretum caffrum. J. Nat. Prod. 1988, 51, 517-527.
41. Polunin, K. E., Schmalz, H.-G., Application of chromium- arene complexes in the organic synthesis. Efficient synth- esis of stilbene phytoalexins. Russian J. Coord. Chem.(Translation of Koordinatsionnaya Khimiya) 2004, 30, 252-261.
42. Orsini, F., Pelizzoni, F., Bellini, B., Miglierini, G., Synthesis of biologically active polyphenolic glycosides (combretastatin and resveratrol series). Carbohydrate Res. 1997, 301, 95-109.
43. Schoene, N. W., Kelly, M. A., Polansky, M. M., Anderson, R. A., Water-soluble polymeric polyphenols from cinnamon inhibit proliferation and alter cell cycle distribution patterns of hematologic tumor cell lines. Cancer Lett. 2005, 230, 134-140.
44. Wang, T. T., Hudson, T. S., Wang, T. C., Remsberg, C. M. et al., Differential effects of resveratrol on androgen-responsive LNCaP human prostate cancer cells in vitro and in vivo. Carcinogenesis 2008, 29, 2001-2010.
45. Kuribayashi, K., Mayes, P. A., El-Deiry, W. S., What are caspases 3 and 7 doing upstream of the mitochondria? Cancer Biol. Ther. 2006, 5, 763-765.
46. 0-Diindolylmethane (DIM) induces a G(1) cell cycle arrest in human breast cancer cells that is accompanied by Sp1-mediated activation of p21(WAF1/CIP1) expression. Carcinogenesis 2002, 23, 1297-1305.
47. Fabiani, R., Rosignoli, P., De Bartolomeo, A., Fuccelli, R., Morozzi, G., Inhibition of cell cycle progression by hydroxy- tyrosol is associated with upregulation of cyclin-dependent protein kinase inhibitors p21(WAF1/Cip1) and p27(Kip1) and with induction of differentiation in HL60 cells. J. Nutr. 2008, 138,42-48.
48. Wenzel, E., Somoza, V., Metabolism and bioavailability of trans-resveratrol. Mol. Nutr. Food Res. 2005, 49, 472-481.